Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jul 1;88(13):5611-5.
doi: 10.1073/pnas.88.13.5611.

Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system

Affiliations

Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system

P Piccioli et al. Proc Natl Acad Sci U S A. .

Abstract

We present a strategy to study functional and/or developmental processes occurring in the nervous system, as well as in other systems, of mice. This strategy is based on the local expression of specific monoclonal antibodies (mAbs) by cells of the nervous system. As an application of this strategy, we report the cloning of the anti-substance P rat mAb NC1/34HL. Functional substance P-binding antibodies were reconstituted from the cloned variable domains by using vectors for expression in myeloma cells. With these and other vectors a general system for the cloning and expression of mAbs under a series of promoters (of the rat VGF8a gene, the neurofilament light-chain gene, and the methallothionein gene) has been created. The activity of these plasmids was confirmed by expressing the recombinant NC1/34HL mAb in GH3 pituitary cells, PC12 pheochromocytoma cells, and COS cells. DNA from the described constructs can be used to target the expression of the NC1/34HL mAb to the central nervous system of transgenic mice. This procedure will allow us to perturb substance P activity in a controlled way in order to dissect its multiple roles.

PubMed Disclaimer

References

    1. FEBS Lett. 1990 Nov 12;274(1-2):193-8 - PubMed
    1. Pharmacol Rev. 1966 Mar;18(1):619-28 - PubMed
    1. Science. 1985 Jul 26;229(4711):345-52 - PubMed
    1. EMBO J. 1987 Sep;6(9):2753-8 - PubMed
    1. Nature. 1988 Aug 18;334(6183):585-91 - PubMed

Publication types

MeSH terms